BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 7904590)

  • 1. Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.
    Costello R; Brailly H; Mallet F; Mawas C; Olive D
    Immunology; 1993 Nov; 80(3):451-7. PubMed ID: 7904590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
    Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells.
    Costello R; Cerdan C; Pavon C; Brailly H; Hurpin C; Mawas C; Olive D
    Eur J Immunol; 1993 Mar; 23(3):608-13. PubMed ID: 8095456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation.
    Cerdan C; Martin Y; Courcoul M; Brailly H; Mawas C; Birg F; Olive D
    J Immunol; 1992 Oct; 149(7):2255-61. PubMed ID: 1356123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B.
    Costello R; Lipcey C; Algarté M; Cerdan C; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Apr; 4(4):329-39. PubMed ID: 8098618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.
    de Jong R; Stokkers P; Lamme E; Kool JM; Borst F; Brouwer M; Miedema F; van Lier RA
    Immunology; 1991 Oct; 74(2):175-82. PubMed ID: 1684171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that activation of human T cells by porcine endothelium involves direct recognition of porcine SLA and costimulation by porcine ligands for LFA-1 and CD2.
    Rollins SA; Kennedy SP; Chodera AJ; Elliott EA; Zavoico GB; Matis LA
    Transplantation; 1994 Jun; 57(12):1709-16. PubMed ID: 7912457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response.
    Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A
    Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation.
    Sansom DM; Wilson A; Boshell M; Lewis J; Hall ND
    Immunology; 1993 Oct; 80(2):242-7. PubMed ID: 7505258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
    Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD59 costimulation of T cell activation. CD58 dependence and requirement for glycosylation.
    Menu E; Tsai BC; Bothwell AL; Sims PJ; Bierer BE
    J Immunol; 1994 Sep; 153(6):2444-56. PubMed ID: 7521361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
    de Waal Malefyt R; Verma S; Bejarano MT; Ranes-Goldberg M; Hill M; Spits H
    Eur J Immunol; 1993 Feb; 23(2):418-24. PubMed ID: 7679643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells.
    Park W; Weyand CM; Schmidt D; Goronzy JJ
    Eur J Immunol; 1997 May; 27(5):1082-90. PubMed ID: 9174596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
    Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
    Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway.
    Lorré K; Fransen L; Ceuppens JL
    Eur Cytokine Netw; 1992; 3(3):321-30. PubMed ID: 1353987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes.
    Damle NK; Klussman K; Linsley PS; Aruffo A
    J Immunol; 1992 Apr; 148(7):1985-92. PubMed ID: 1372018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 alpha is produced by T lymphocytes activated via the CD2 plus CD28 pathways.
    Cerdan C; Martin Y; Brailly H; Courcoul M; Flavetta S; Costello R; Mawas C; Birg F; Olive D
    J Immunol; 1991 Jan; 146(2):560-4. PubMed ID: 1670946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes.
    Conlon KC; Ochoa AC; Kopp WC; Ortaldo JR; Urba WJ; Longo DL; Young HA
    J Immunol; 1992 Nov; 149(10):3278-89. PubMed ID: 1358968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.